in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—27 November
9:46 AM MST | November 27, 2012 | Deepti Ramesh and Sotirios Frantzanas
BASF to acquire Pronova BioPharma for $842 million BASF says it will acquire Pronova BioPharma (Lysaker, Norway), a pioneer in the field of research, development, and manufacturing of omega-3 fatty acids. BASF has reached an agreement with Pronova to make a recommended voluntary public takeover offer to Pronova’s shareholders, and will offer to pay 12.50 Norwegian krone in cash for each Pronova share. Based on all outstanding shares and including all financial liabilities, the enterprise value would be NK4.84 billion ($842 million), BASF says. BASF expects...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee